胱抑素C和心血管疾病危险因素的关系

陈俊华, 李孝华. 胱抑素C和心血管疾病危险因素的关系[J]. 心脏杂志, 2013, 25(2): 250-253.

引用本文:

陈俊华, 李孝华. 胱抑素C和心血管疾病危险因素的关系[J]. 心脏杂志, 2013, 25(2): 250-253.

Cystatin C and cardiovascular risks[J]. Chinese Heart Journal, 2013, 25(2): 250-253.

Citation:

Cystatin C and cardiovascular risks[J]. Chinese Heart Journal, 2013, 25(2): 250-253.

Cystatin C and cardiovascular risks

摘要: 半胱氨酸蛋白酶抑制剂（简称胱抑素C）是评价肾小球功能-肾小球滤过率最理想的指标之一。目前发现，胱抑素C与心血管疾病的发生及预后有密切关系。现就胱抑素C与心血管疾病危险关系的相关性做以下综述。

Abstract: Cystatin C has been proposed as a good indicator of assessing renal function glomerular filtration rate (GFR). Patients with higher circulating cystatin C concentrations appear to have an increased cardiovascular risk profile. This report presents a review of the role of cystatin C as a predictor of cardiovascular risks.

/